Test allergens are used for the diagnosis of allergies to the tested allergens. Depending on the application type, these test allergens are allocated to specific categories.
Intracutaneous tests serve to detect whether sensitisations to an allergen are present. Intracutaneous tests can also be to detect sensitisations to weak allergen. To do this, the test allergen is injected intracutaneously, i.e. into the layer of the skin called dermis using a fine needle.
Test allergens for intracutaneous tests are available for the following allergen classes:
House dust mites and Storage mites
Updated: 25.04.2025
Approved test allergens for intracutaneous tests for the detection of allergies to Tree Pollen
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
Approved test allergens for intracutaneous tests for the detection of allergies to Grass-, Cereal- or Herbal Pollen
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
Approved test allergens for intracutaneous tests for the detection of allergies to House dust mites or Storage mites
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 528 in BAnz AT 25.04.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 25.04.2025
